L-THREONINE DECORATED PACLITAXEL POLY (L-LACTIDE) NANOPARTICLES: FORMULATION, PHARMACOKINETIC AND STABILITY STUDY
Main Article Content
Keywords
Surface-modification, stability, nanoparticle, , L-threonine
Abstract
A lot of research has been done on surface modification of nanoparticles to enhance the kinetics of drug release. The formulation of paclitaxel-loaded poly (L-lactide) nanoparticles conjugated with L-threonine as the surface-modifying ligand has been described in this study, along with the formulation's in vivo release kinetics in comparison to pure drug solution and stability analysis under various storage conditions. According to the study's findings, the particles had an average size of 200 nm or less, had an encapsulation efficacy of 92.6 percent, and released continuously for 24 hours. The drug's nanoparticle elimination half-life was dramatically lengthened. The most stable storage settings for the nanoparticles were determined to be in a refrigerator.
References
2. Proffitt RT, Williams LE, Presant CA, Tin GW, Ulina JA, Gamble RC, Baldeschwieler JD (1983) Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science 220: 502-505.
3. Gref R, Minamitake Y, Peracchia MT, Trubetskov V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263: 1600-1603.
4. Storm G, Belliot SO, Daemen T, Lasic DD (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocytic system. Adv Drug Del Rev 17: 31-48.
5. Kaul G, Amiji M (2002) Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res 19: 1061-1067.
6. Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J (1999) Significant transport of doxorubicin into the brain with polysorbate 80- coated nanoparticles. Pharm Res 16: 1564-1569.
7. Kaul G, Amiji M (2004) Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J Drug Target 12: 585-591.
8. Benjamin GD, Mark AR (2002) Drug delivery systems based on sugar-macromolecular conjugates. Curr Opin Drug Del 5 (2): 279-288.
9. Egleton RD, Mitchell SA, Huber JD, Palian MM, Polt R, Davis TP (2001) Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptided by glycosylation. J Pharm Exper Ther 299 (3): 967-972.
10. Tosi G, Rivasi F, Gandolfi F, Costantino L, Vandelli MA, Forni F (2005) Conjugated poly (D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles. Biomater 26:4189-4195.
11. Zhiping Z, Sie Huey Lee, Si-Shen Feng (2007) Folate-decorated poly (lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomater 28: 1889-1899.
12. Sun W, Xie C, Wang H, Hu Y (2004) Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomater 25: 3065-3071.
13. Quirk RA, Chan WC, Davies MC, Tendler SJB, Shakeshe KM (2001) Poly (L-lysine) GRGDS as a biomimetic surface modifier for poly (lactic acid). Biomater 22: 865-872.
14. Fahmy TM, Samstein RM, Harness CC, Mark Saltzman W (2005) Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomater 26: 5727-5736.
15. Lirong C (2005) Nanoparticles of biodegradable polymers for delivery of therapeutic agents and diagnostic sensitizers to cross the blood brain barrier for chemotherapy and mri of the brain. Masters thesis: National university of Singapore
16. Aterman KC (2007) A critical review of gastro retentive controlled drug delivery Pharm Dev Technol 12: 1-10.
17. Rajender G, Narayanan NGB (2009) Sensitive and validated HPLC method for determination of paclitaxel in human serum. Indian J Sci Technol 2 (5): 52-54.
18. Mishra BJ, Trivedi P (2013) Formulation, stability and pharmacokinetic study of paclitaxel loaded poly(L-lactide) nanoparticles. Digest J Nanomater Biostruct 8: 1829-1833
19. Mishra BJ, Kaul A, Trivedi P (2015) L-Cysteine conjugated poly-L-lactide nanoparticles containing 5-fluorouracil: Formulation, characterization, release and uptake by tissues in vivo. Drug Delivery 22 (2): 214-222.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.